Stay updated on Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Sign up to get notified when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.

Latest updates to the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s footer/version label was updated from one site revision to the next (v3.5.2 → v3.5.3), indicating a platform release rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a backend update with no impact on study data or patient-facing content.SummaryDifference0.1%

- Check35 days agoChange DetectedScreenshots show only visual/layout changes with no modification to the study's main content.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded 'Cutaneous neuroendocrine carcinoma' as a related topic and a 'Genetic and Rare Diseases Information Center' resource under the Resources section.SummaryDifference0.2%

- Check58 days agoChange DetectedSite version updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check65 days agoChange DetectedMetadata revision updates were applied: a new Revision: v3.4.3 and recent date stamps (2026-03-11, 2026-09-19, 2026-02-26, 2026-02) were added. The previous Revision: v3.4.2 and older date stamps (e.g., 2025-12-22, 2025-12-04, 2025-12) were removed.SummaryDifference0.3%

Stay in the know with updates to Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.